Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma.

Hartleb, J

Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma. [electronic resource] - Journal of chromatography. B, Biomedical sciences and applications Apr 1999 - 31-42 p. digital

Publication Type: Journal Article

1387-2273

10.1016/s0378-4347(99)00098-5 doi


Automation
Biomarkers, Tumor--blood
Calibration
Case-Control Studies
Chromatography, High Pressure Liquid--methods
Cysteinyldopa--blood
Humans
Melanoma--blood
Prognosis
Reference Standards
Reproducibility of Results
Sensitivity and Specificity
Skin Neoplasms--blood